Jonathan R. Walker

Jonathan R. Walker

Auto-generated profile, based on publicly available information

Jonathan R. Walker

Institute of Cardiovascular Sciences

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

20 July 2010 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
JWJonathan Walker
Jonathan Walker
NBNavdeep Bhullar
Navdeep Bhullar
NFNazanin Fallah-Rad
Nazanin Fallah-Rad
MLMatthew Lytwyn
Matthew Lytwyn
MGMehrdad Golian
Mehrdad Golian
DJDavinder S. Jassal
Davinder S. Jassal
Purpose In patients with breast cancer, the administration of doxorubicin and trastuzumab is associated with an increased risk of cardiotoxicity. Although multiple-gated acquisition (MUGA) scans and two-dimensional transthoracic echocardiography (TTE) are conventional methods for baseline and serial assessment of left ventricular ejection fraction (LVEF) in these patients, little is known about the use of real-time three-dimensional TTE (RT3D TTE) in this clinical setting. The aim of this study was to assess the accuracy of MUGA, 2D TTE, and RT3D TTE for determining LVEF in comparison to cardiac magnetic resonance imaging (CMR). Methods Between 2007 and 2009 inclusive, 50 female patients with human epidermal growth factor receptor 2–positive breast cancer received adjuvant trastuzumab after doxorubicin. Serial MUGA, 2D TTE, RT3D TTE, and CMR were performed at baseline, 6, and 12 months after the initiation of trastuzumab. Results A comparison of left ventricular end diastolic volume (LVEDV) demonstrated a modest correlation between 2D TTE and CMR (r = 0.64 at baseline; r = 0.69 at 12 months, respectively). A comparison of LVEDV between RT3D TTE and CMR demonstrated a stronger correlation (r = 0.87 at baseline; r = 0.95 at 12 months, respectively). Although 2D TTE demonstrated a weak correlation with CMR for LVEF assessment (r = 0.31 at baseline, r = 0.42 at 12 months, respectively), both RT3D TTE and MUGA showed a strong correlation when compared with CMR (r = 0.91 at baseline; r = 0.90 at 12 months, respectively). Conclusion As compared with conventional MUGA, RT3D TTE is a feasible, accurate, and reproducible alternate imaging modality for the serial monitoring of LVEF in patients with breast cancer.

1 May 2009 in The American Journal of Cardiology
Verified
Journal Article
Closed access
NMNegareh Mousavi
Negareh Mousavi
ACAndrew Czarnecki
Andrew Czarnecki
KKKanwal Kumar
Kanwal Kumar
NFNazanin Fallah-Rad
Nazanin Fallah-Rad
MLMatthew Lytwyn
Matthew Lytwyn
DJDavinder S. Jassal
Davinder S. Jassal

1 March 2012 in Chest
Verified
Journal Article
Closed access
PDF file
JCJane Colish
Jane Colish
JWJonathan R. Walker
Jonathan R. Walker
NENader Elmayergi
Nader Elmayergi
SASaleh Almutairi
Saleh Almutairi
FAFawaz Alharbi
Fawaz Alharbi
DJDavinder S. Jassal
Davinder S. Jassal

10 December 2008 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
DWDeepa Wadhwa
Deepa Wadhwa
NFNazanin Fallah-Rad
Nazanin Fallah-Rad
DGDebjani Grenier
Debjani Grenier
MKMarianne Krahn
Marianne Krahn
TFTielan Fang
Tielan Fang
DJDavinder S. Jassal
Davinder S. Jassal

1 April 2009 in Journal of the American Society of Echocardiography
Verified
Journal Article
Closed access
DJDavinder S. Jassal
Davinder S. Jassal
SHSong-Yee Han
Song-Yee Han
CHCecilia Hans
Cecilia Hans
ASAnita Sharma
Anita Sharma
TFTielan Fang
Tielan Fang
PSPawan K. Singal
Pawan K. Singal